Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 March 2021 | Story Lacea Loader

 



The Council of the University of the Free State (UFS) confirmed the following at its meeting on 19 March 2021:


1. Its support of and confidence in the leadership of the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen and his team, and duly recognises the efforts and results achieved at the University during the challenges posed by the COVID-19 pandemic, as well as the current nationwide student protest on the payment of student debt.

2. In this context, the Council also distances itself and deplores the statements made by the leadership of the Institutional Student Representative Council (ISRC), on national television on Monday 15 March 2021,   as it pertained to the demand for the immediate resignation of the Rector and Vice-Chancellor, and the statements pertaining to the Chancellor, Prof Bonang Mohale, and Chairperson of the Council, Dr Willem Louw. The Council notes that Mr Katleho Lechoo, President of the ISRC subsequently retracted the utterances.

3. The Council strongly affirms its confidence in the relationship between the leadership of the UFS and the ISRC and expresses its appreciation for the University leadership’s commitment to continuously engage with students about matters of concern to them. The Council furthermore encourages positive and constructive engagement by the ISRC with the University leadership, as this contributes to shared-understanding of the challenges faced by the South African higher education sector and the governance of the UFS.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept